Chiron files suit against Genentech

CHIR is alleging that the manufacture and sale of Herceptin trastuzumab, DNA's anti-HER-2 monoclonal antibody to treat breast cancer, infringes CHIR's U.S. Patent No. 6,054,561. The patent, issued Apr...